Alphanate (GRIFOLS USA, LLC)
Welcome to the PulseAid listing for the Alphanate drug offered from GRIFOLS USA, LLC. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | GRIFOLS USA, LLC |
NON-PROPRIETARY NAME: | Antihemophilic Factor/von Willebrand Factor Complex (Human) |
SUBSTANCE NAME: | |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2007-01-31 |
END MARKETING DATE: | 0000-00-00 |
Alphanate PLASMA DERIVATIVE Details:
Item Description | Alphanate from GRIFOLS USA, LLC |
LABELER NAME: | GRIFOLS USA, LLC |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2007-01-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68516-4601_8af93b52-b2cc-132b-c045-301af07df0e9 |
PRODUCT NDC: | 68516-4601 |
APPLICATION NUMBER: | BLA102475 |